Goodbody Health Stock Canadian Securities Exchange
Equities
SWEL
CA3821591011
Pharmaceuticals
Sales 2020 | 1.99M 2.5M 3.42M | Sales 2021 | 17.06M 21.35M 29.22M | Capitalization | 13.76M 17.22M 23.56M |
---|---|---|---|---|---|
Net income 2020 | -4M -5.01M -6.85M | Net income 2021 | -2M -2.5M -3.43M | EV / Sales 2020 | 5.41 x |
Net cash position 2020 | 1.37M 1.72M 2.35M | Net cash position 2021 | 5.73M 7.17M 9.82M | EV / Sales 2021 | 0.47 x |
P/E ratio 2020 |
-1.4
x | P/E ratio 2021 |
-5.64
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 70.26% |
Managers | Title | Age | Since |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Anne Tew
SEC | Corporate Secretary | - | 18-10-31 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.16B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |